4.6 Article

Aberrant Excitatory-Inhibitory Synaptic Mechanisms in Entorhinal Cortex Microcircuits During the Pathogenesis of Alzheimer's Disease

期刊

CEREBRAL CORTEX
卷 29, 期 4, 页码 1834-1850

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cercor/bhz016

关键词

Alzheimer's disease; GABA(A) receptor; interneurons; synapse; Wnt signaling

资金

  1. Wellcome Trust (UK) [GO501263]
  2. Medical Research Council (UK) [GO501263]
  3. Medical Research Council [MR/M00676X/1]
  4. Medical Research Council [MR/M00676X/1] Funding Source: researchfish
  5. MRC [MR/M00676X/1, 1766911] Funding Source: UKRI

向作者/读者索取更多资源

Synaptic dysfunction is widely proposed as an initial insult leading to the neurodegeneration observed in Alzheimer's disease (AD). We hypothesize that the initial insult originates in the lateral entorhinal cortex (LEC) due to deficits in key interneuronal functions and synaptic signaling mechanisms, in particular, Wnt (Wingless/integrated). To investigate this hypothesis, we utilized the first knock-in mouse model of AD (App(NL-F/NL-F)), expressing a mutant form of human amyloid-beta (A beta) precursor protein. This model shows an age-dependent accumulation of A beta, neuroinflammation, and neurodegeneration. Prior to the typical AD pathology, we showed a decrease in canonical Wnt signaling activity first affecting the LEC in combination with synaptic hyperexcitation and severely disrupted excitatory-inhibitory inputs onto principal cells. This synaptic imbalance was consistent with a reduction in the number of parvalbumin-containing (PV) interneurons, and a reduction in the somatic inhibitory axon terminals in the LEC compared with other cortical regions. However, targeting GABA(A) receptors on PV cells using allosteric modulators, diazepam, zolpidem, or a nonbenzodiazepine, L-838,417 (modulator of alpha 2/3 subunit-containing GABAA receptors), restored the excitatory-inhibitory imbalance observed at principal cells in the LEC. These data support our hypothesis, providing a rationale for targeting the synaptic imbalance in the LEC for early stage therapeutic intervention to prevent neurodegeneration in AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据